|
|
||||||||
Published online before print July 24, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

* Department of Pathology and Immunology, Centre Médical Universitaire, Geneva, Switzerland; and
Department of Neurological Surgery and Brain Tumor Research Center, University of California San Francisco, San Fransico, California
1 Correspondence: Department of Pathology and Immunology, Centre Médical Universitaire, 1204, Geneva, Switzerland. E-mail: Beat.Imhof{at}medecine.unige.ch
ABSTRACT
During the neoplastic progression, macrophages as well as dendritic and NK cells are attracted into the tumor site and initiate the immune response against transformed cells. They activate and present tumor antigens to T cells, which are then activated to kill tumor cells. However, tumor cells are often capable of escaping the immune machinery. As the immune surveillance is not sufficient anymore, tumor-associated macrophages contribute to tumor progression. It is notable that tumor-associated macrophages promote the proliferation of tumor cells directly by secreting growth factors. They also participate in tumor progression by acting on endothelial cells and thus promoting the neovascularization of the tumor. Tumor-associated macrophages are indeed key protagonists during angiogenesis and promote each step of the angiogenesis cascade.
Key Words: chemokines neovascularization monocytes
This article has been cited by other articles:
![]() |
U. Tigges, E. G. Hyer, J. Scharf, and W. B. Stallcup FGF2-dependent neovascularization of subcutaneous Matrigel plugs is initiated by bone marrow-derived pericytes and macrophages Development, February 1, 2008; 135(3): 523 - 532. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |